Table 3.
Number of studies (lesions examined) | Sensitivity (95%CI) | Specificity (95%CI) | AUC |
I2 |
||
Sensitivity | Specificity | |||||
Overall | 14 (2433) | 0.86 (0.83-0.89) | 0.96 (0.95-0.97) | 0.9623 | 75.4% | 86.9% |
Type of lesion | ||||||
Depressed | 3 (605) | 0.64 (0.52-0.75) | 0.96 (0.95-0.98) | 0.7877 | 0.0% | 74.1% |
Not depressed | 10 (1828) | 0.90 (0.86-0.92) | 0.96 (0.95-0.97) | 0.9694 | 64.9% | 90.1% |
Diagnosis standard | ||||||
Diagnosis (IMVP/IMSP + DL) | 7 (1613) | 0.81 (0.76-0.85) | 0.97 (0.96-0.98) | 0.9407 | 78.0% | 88.8% |
Diagnosis (others) | 7 (820) | 0.93 (0.89-0.96) | 0.93 (0.91-0.95) | 0.9719 | 36.6% | 80.5% |
Lesion size | ||||||
Diameter (> 10 mm) | 8 (777) | 0.90 (0.86-0.93) | 0.88 (0.85-0.91) | 0.9585 | 71.2% | 44.7% |
Diameter (≤ 10 mm) | 5 (1449) | 0.74 (0.65-0.82) | 0.98 (0.97-0.98) | 0.9458 | 67.1% | 86.6% |
Sample size | ||||||
≥ 100 patients | 8 (2035) | 0.84 (0.79-0.88) | 0.97 (0.96-0.97) | 0.9663 | 79.1% | 90.7% |
< 100 patients | 6 (398) | 0.90 (0.85-0.93) | 0.87 (0.81-0.92) | 0.9422 | 67.3% | 0.0% |
Type of assessment | ||||||
Real-time | 8 (1310) | 0.85 (0.81-0.90) | 0.95 (0.94-0.96) | 0.9617 | 81.6% | 81.2% |
Post-procedure | 6 (1123) | 0.87 (0.82-0.91) | 0.97 (0.95-0.98) | 0.9608 | 65.5% | 91.6% |
Country | ||||||
China | 3 (1014) | 0.94 (0.88-0.97) | 0.98 (0.97-0.99) | 0.9864 | 62.5% | 95.7% |
Japan | 11 (1419) | 0.84 (0.80-0.88) | 0.94 (0.92-0.95) | 0.9526 | 74.6% | 71.2% |
I2 > 50% was considered significant for heterogeneity. AUC: Area under the curve.